Oncostability: stability of reconstituted and diluted anticancer medicines for a possible extension of use

Eur J Hosp Pharm. 2023 Mar;30(e1):e112. doi: 10.1136/ejhpharm-2021-003157. Epub 2021 Dec 15.

¹ Scientific Direction, Italian Society for Clinical Pharmacy and Therapeutics, Milan, Italy.
² Clinical Oncology Pharmacy, Azienda Ospedaliera Brotzu, Cagliari, Italy melania.rivano@gmail.com.
³ Hospital Pharmacy Department, Ausl Modena, Modena, Italy.
⁴ Department of Pharmacy, IRCCS National Cancer Institute, Milano, Lombardia, Italy.
⁵ Hospital Pharmacy Department, University Hospital Policlinico, Bari, Italy.
⁶ Hospital Pharmacy Department, S.Chiara Hospital, Trento, Italy.
⁷ Azienda Sanitaria Universitaria Integrata Giuliano Isontina, Trieste, Italy.
⁸ Hospital Pharmacy Department, Azienda Ospedale - Università of Padova, Padova, Italy.
⁹ Presidency, SIFaCT President, Italian Society for Clinical Pharmacy and Therapy, Milano, Italy.

No abstract available

Keywords: antineoplastic agents; drug compounding; education; hospital; pharmaceutical preparations; pharmacy; pharmacy service.

Publication types